Impact of the COVID-19 pandemic on therapeutic management of rheumatoid arthritis in Brittany (France)

•This is the first study that looks at the impact of the COVID-19 pandemic on RA therapeutic management in France.•This study shows that the optimal DMARD treatment was impacted by the pandemic in around 10% of RA patients.•In most cases, treatment modification was the consequence of a patient'...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Joint, bone, spine : revue du rhumatisme bone, spine : revue du rhumatisme, 2021-07, Vol.88 (4), p.105179-105179, Article 105179
Hauptverfasser:	Queré, Baptiste, Saraux, Alain, Marhadour, Thierry, Jousse-Joulin, Sandrine, Cornec, Divi, Houssais, Camille, Carvajal Alegria, Guillermo, Quiviger, Maxime, Le Guillou, Margot, Devauchelle-Pensec, Valérie, Guellec, Dewi
Format:	Artikel
Sprache:	eng
Schlagworte:	Letter to the Editor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	•This is the first study that looks at the impact of the COVID-19 pandemic on RA therapeutic management in France.•This study shows that the optimal DMARD treatment was impacted by the pandemic in around 10% of RA patients.•In most cases, treatment modification was the consequence of a patient's decision rather than a decision driven by a healthcare professional.
ISSN:	1297-319X 1778-7254
DOI:	10.1016/j.jbspin.2021.105179